Supplementary file - Efficacy and safety of methotrexate add-on therapy versus placebo for patients with chronic spontaneous urticaria resistant to H1-antihistamines: a randomized, controlled trial
Published: 30-07-2019| Version 1 | DOI: 10.17632/82k28wzxmr.1
Contributor:
Sophie Leducq
Description
Supplementary data for the publication by Leducq S. et al. Efficacy and safety of methotrexate add-on therapy versus placebo for patients with chronic spontaneous urticaria resistant to H1-antihistamines: a randomized, controlled trial. J Am Acad Dermatol 2019.